Literature DB >> 4067329

Cell kinetic basis for pathophysiology of psoriasis.

G D Weinstein, J L McCullough, P A Ross.   

Abstract

Studies on the cell proliferation kinetics of psoriatic epidermal cells are presented and the results compared to similar studies for normal epidermis. The short 36-h duration of the psoriatic cell cycle (Tc) is confirmed with the first double-peaked fraction of labeled mitoses (FLM) curve in human subjects. The growth fraction of psoriasis using two experimental techniques approximates 100% within 36 h, confirming the rapid Tc found by the FLM method. The cell kinetic basis for the pathophysiology of psoriasis consists of at least 3 proliferative abnormalities in comparison to normal epidermis. By far the largest alteration is the shortening of the Tc from 311 to 36 h. There is also a doubling of the proliferative cell population in psoriasis from 27,000 to 52,000 cells/mm and an increase in the growth fraction from 60% to 100%. As a consequence of these abnormalities the psoriatic epidermis produces 35,000 cells/day from a proliferative compartment of 52,000 cells/mm2 surface area. This is a 28-fold greater production of cells than the 1,246 cells/day produced in normal epidermis. The biochemical or control factors leading to these kinetic differences continue to remain elusive.

Entities:  

Mesh:

Year:  1985        PMID: 4067329     DOI: 10.1111/1523-1747.ep12283594

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal.

Authors:  T Simonart; M Heenen; O Lejeune
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

2.  Modelling epidermis homoeostasis and psoriasis pathogenesis.

Authors:  Hong Zhang; Wenhong Hou; Laurence Henrot; Sylvianne Schnebert; Marc Dumas; Catherine Heusèle; Jin Yang
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

3.  The distribution of cellular turnover in the human body.

Authors:  Ron Sender; Ron Milo
Journal:  Nat Med       Date:  2021-01-11       Impact factor: 53.440

Review 4.  Psoriatic science.

Authors:  C M Rowland Payne
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

5.  A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis.

Authors:  P E Van Erp; S De Mare; J J Rijzewijk; P C Van de Kerkhof; F W Bauer
Journal:  Histochem J       Date:  1989-06

6.  Evidence for altered Wnt signaling in psoriatic skin.

Authors:  Johann E Gudjonsson; Andrew Johnston; Stefan W Stoll; Mary B Riblett; Xianying Xing; James J Kochkodan; Jun Ding; Rajan P Nair; Abhishek Aphale; John J Voorhees; James T Elder
Journal:  J Invest Dermatol       Date:  2010-04-08       Impact factor: 8.551

7.  Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.

Authors:  R P Carlson; L O'Neill-Davis; W Calhoun; L Datko; J H Musser; A F Kreft; J Y Chang
Journal:  Agents Actions       Date:  1989-03

Review 8.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

9.  Methotrexate induces differentiation of human keratinocytes.

Authors:  P M Schwartz; S K Barnett; E S Atillasoy; L M Milstone
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

10.  Enhanced expression of ras gene products in psoriatic epidermis.

Authors:  H Kobayashi; H Yasuda; A Ohkawara; H Dosaka; A Oda; Y Ogiso; N Kuzumaki
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.